MiRNA–based treatment for NIDDM: MiRNA-9 promotes insulin sensisivity via down regulation of E3 ubiquitin-protein ligase CBL, 14/July/2014, 5.26 am

MiRNA–based treatment for NIDDM: MiRNA-9 promotes insulin sensisivity via down regulation of E3 ubiquitin-protein ligase CBL, 14/July/2014, 5.26 am

MiRNA–based treatment for NIDDM: MiRNA-9 promotes insulin sensisivity via down regulation of E3 ubiquitin-protein ligase CBL, 14/July/2014, 5.26 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA–based treatment for NIDDM: MiRNA-9 promotes insulin sensisivity via down regulation of  E3 ubiquitin-protein ligase CBL, 14/July/2014, 5.26 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org